Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
In 2017, the global Anti-Depressant market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Anti-Depressant market based on company, product type, application and key regions.
This report studies the global market size of Anti-Depressant in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Depressant in these regions.
This research report categorizes the global Anti-Depressant market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Anti-Depressant include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-Depressant include
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
TEVA PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL
Market Size Split by Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Market Size Split by Application
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-Depressant market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anti-Depressant market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-Depressant manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Depressant with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-Depressant submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anti-Depressant are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Depressant market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
In 2017, the global Anti-Depressant market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Anti-Depressant market based on company, product type, application and key regions.
This report studies the global market size of Anti-Depressant in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Depressant in these regions.
This research report categorizes the global Anti-Depressant market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Anti-Depressant include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-Depressant include
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
TEVA PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL
Market Size Split by Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Market Size Split by Application
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-Depressant market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anti-Depressant market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-Depressant manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Depressant with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-Depressant submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anti-Depressant are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Depressant market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Anti-Depressant Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Depressant Market Size Growth Rate by Type
1.4.2 Tricyclic Antidepressants
1.4.3 Selective Serotonin Reuptake Inhibitors
1.4.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.4.5 Monoamine Oxidase Inhibitors
1.4.6 Serotonin Antagonist
1.4.7 Reuptake Inhibitors
1.4.8 Others
1.5 Market by Application
1.5.1 Global Anti-Depressant Market Size Growth Rate by Application
1.5.2 Major Depressive Disorder
1.5.3 Obsessive-Compulsive Disorder
1.5.4 Generalized Anxiety Disorder
1.5.5 Panic Disorder
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Depressant Market Size
2.1.1 Global Anti-Depressant Revenue 2016-2025
2.1.2 Global Anti-Depressant Sales 2016-2025
2.2 Anti-Depressant Growth Rate by Regions
2.2.1 Global Anti-Depressant Sales by Regions
2.2.2 Global Anti-Depressant Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-Depressant Sales by Manufacturers
3.1.1 Anti-Depressant Sales by Manufacturers
3.1.2 Anti-Depressant Sales Market Share by Manufacturers
3.1.3 Global Anti-Depressant Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Depressant Revenue by Manufacturers
3.2.1 Anti-Depressant Revenue by Manufacturers (2016-2018)
3.2.2 Anti-Depressant Revenue Share by Manufacturers (2016-2018)
3.3 Anti-Depressant Price by Manufacturers
3.4 Anti-Depressant Manufacturing Base Distribution, Product Types
3.4.1 Anti-Depressant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Depressant Product Category
3.4.3 Date of International Manufacturers Enter into Anti-Depressant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Anti-Depressant Sales by Type
4.2 Global Anti-Depressant Revenue by Type
4.3 Anti-Depressant Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Anti-Depressant Breakdown Data by Application
6 North America
6.1 North America Anti-Depressant by Countries
6.1.1 North America Anti-Depressant Sales by Countries
6.1.2 North America Anti-Depressant Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Depressant by Type
6.3 North America Anti-Depressant by Application
6.4 North America Anti-Depressant by Company
7 Europe
7.1 Europe Anti-Depressant by Countries
7.1.1 Europe Anti-Depressant Sales by Countries
7.1.2 Europe Anti-Depressant Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Depressant by Type
7.3 Europe Anti-Depressant by Application
7.4 Europe Anti-Depressant by Company
8 Asia Pacific
8.1 Asia Pacific Anti-Depressant by Countries
8.1.1 Asia Pacific Anti-Depressant Sales by Countries
8.1.2 Asia Pacific Anti-Depressant Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Depressant by Type
8.3 Asia Pacific Anti-Depressant by Application
8.4 Asia Pacific Anti-Depressant by Company
9 Central & South America
9.1 Central & South America Anti-Depressant by Countries
9.1.1 Central & South America Anti-Depressant Sales by Countries
9.1.2 Central & South America Anti-Depressant Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Depressant by Type
9.3 Central & South America Anti-Depressant by Application
9.4 Central & South America Anti-Depressant by Company
10 Middle East and Africa
10.1 Middle East and Africa Anti-Depressant by Countries
10.1.1 Middle East and Africa Anti-Depressant Sales by Countries
10.1.2 Middle East and Africa Anti-Depressant Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Depressant by Type
10.3 Middle East and Africa Anti-Depressant by Application
10.4 Middle East and Africa Anti-Depressant by Company
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.1.4 Anti-Depressant Product Description
11.1.5 Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.2.4 Anti-Depressant Product Description
11.2.5 Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.3.4 Anti-Depressant Product Description
11.3.5 Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.4.4 Anti-Depressant Product Description
11.4.5 Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.5.4 Anti-Depressant Product Description
11.5.5 Recent Development
11.6 Lundbeck
11.6.1 Lundbeck Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.6.4 Anti-Depressant Product Description
11.6.5 Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.7.4 Anti-Depressant Product Description
11.7.5 Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.8.4 Anti-Depressant Product Description
11.8.5 Recent Development
11.9 TEVA PHARMACEUTICAL INDUSTRIES
11.9.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.9.4 Anti-Depressant Product Description
11.9.5 Recent Development
11.10 TAKEDA PHARMACEUTICAL
11.10.1 TAKEDA PHARMACEUTICAL Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.10.4 Anti-Depressant Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Anti-Depressant Raw Material
13.1.2 Anti-Depressant Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
1 Study Coverage
1.1 Anti-Depressant Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Depressant Market Size Growth Rate by Type
1.4.2 Tricyclic Antidepressants
1.4.3 Selective Serotonin Reuptake Inhibitors
1.4.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.4.5 Monoamine Oxidase Inhibitors
1.4.6 Serotonin Antagonist
1.4.7 Reuptake Inhibitors
1.4.8 Others
1.5 Market by Application
1.5.1 Global Anti-Depressant Market Size Growth Rate by Application
1.5.2 Major Depressive Disorder
1.5.3 Obsessive-Compulsive Disorder
1.5.4 Generalized Anxiety Disorder
1.5.5 Panic Disorder
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Depressant Market Size
2.1.1 Global Anti-Depressant Revenue 2016-2025
2.1.2 Global Anti-Depressant Sales 2016-2025
2.2 Anti-Depressant Growth Rate by Regions
2.2.1 Global Anti-Depressant Sales by Regions
2.2.2 Global Anti-Depressant Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-Depressant Sales by Manufacturers
3.1.1 Anti-Depressant Sales by Manufacturers
3.1.2 Anti-Depressant Sales Market Share by Manufacturers
3.1.3 Global Anti-Depressant Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Depressant Revenue by Manufacturers
3.2.1 Anti-Depressant Revenue by Manufacturers (2016-2018)
3.2.2 Anti-Depressant Revenue Share by Manufacturers (2016-2018)
3.3 Anti-Depressant Price by Manufacturers
3.4 Anti-Depressant Manufacturing Base Distribution, Product Types
3.4.1 Anti-Depressant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Depressant Product Category
3.4.3 Date of International Manufacturers Enter into Anti-Depressant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Anti-Depressant Sales by Type
4.2 Global Anti-Depressant Revenue by Type
4.3 Anti-Depressant Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Anti-Depressant Breakdown Data by Application
6 North America
6.1 North America Anti-Depressant by Countries
6.1.1 North America Anti-Depressant Sales by Countries
6.1.2 North America Anti-Depressant Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Depressant by Type
6.3 North America Anti-Depressant by Application
6.4 North America Anti-Depressant by Company
7 Europe
7.1 Europe Anti-Depressant by Countries
7.1.1 Europe Anti-Depressant Sales by Countries
7.1.2 Europe Anti-Depressant Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Depressant by Type
7.3 Europe Anti-Depressant by Application
7.4 Europe Anti-Depressant by Company
8 Asia Pacific
8.1 Asia Pacific Anti-Depressant by Countries
8.1.1 Asia Pacific Anti-Depressant Sales by Countries
8.1.2 Asia Pacific Anti-Depressant Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Depressant by Type
8.3 Asia Pacific Anti-Depressant by Application
8.4 Asia Pacific Anti-Depressant by Company
9 Central & South America
9.1 Central & South America Anti-Depressant by Countries
9.1.1 Central & South America Anti-Depressant Sales by Countries
9.1.2 Central & South America Anti-Depressant Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Depressant by Type
9.3 Central & South America Anti-Depressant by Application
9.4 Central & South America Anti-Depressant by Company
10 Middle East and Africa
10.1 Middle East and Africa Anti-Depressant by Countries
10.1.1 Middle East and Africa Anti-Depressant Sales by Countries
10.1.2 Middle East and Africa Anti-Depressant Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Depressant by Type
10.3 Middle East and Africa Anti-Depressant by Application
10.4 Middle East and Africa Anti-Depressant by Company
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.1.4 Anti-Depressant Product Description
11.1.5 Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.2.4 Anti-Depressant Product Description
11.2.5 Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.3.4 Anti-Depressant Product Description
11.3.5 Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.4.4 Anti-Depressant Product Description
11.4.5 Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.5.4 Anti-Depressant Product Description
11.5.5 Recent Development
11.6 Lundbeck
11.6.1 Lundbeck Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.6.4 Anti-Depressant Product Description
11.6.5 Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.7.4 Anti-Depressant Product Description
11.7.5 Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.8.4 Anti-Depressant Product Description
11.8.5 Recent Development
11.9 TEVA PHARMACEUTICAL INDUSTRIES
11.9.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.9.4 Anti-Depressant Product Description
11.9.5 Recent Development
11.10 TAKEDA PHARMACEUTICAL
11.10.1 TAKEDA PHARMACEUTICAL Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Anti-Depressant
11.10.4 Anti-Depressant Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Anti-Depressant Raw Material
13.1.2 Anti-Depressant Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.